Gender and clinical trials: is the Regulation n. 536/2914 (EU) a missed opportunity?. BioLaw [Internet]. 2022 Dec. 23 [cited 2026 Jul. 7];(4):251-76. Available from: https://teseo-ojs35-test.archicoop.it/biolaw/article/view/2478